|
UGP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.90890000765165E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.34579997041118E-09 |
| Normal-vs-Stage2 |
3.295800E-01 |
| Normal-vs-Stage3 |
7.421400E-04 |
| Normal-vs-Stage4 |
2.977600E-02 |
| Stage1-vs-Stage2 |
2.568300E-02 |
| Stage1-vs-Stage3 |
5.233000E-01 |
| Stage1-vs-Stage4 |
7.789200E-01 |
| Stage2-vs-Stage3 |
1.655630E-01 |
| Stage2-vs-Stage4 |
1.615620E-01 |
| Stage3-vs-Stage4 |
5.288800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.33739957681223E-10 |
| Normal-vs-AfricanAmerican |
3.936300E-03 |
| Normal-vs-Asian |
6.923000E-01 |
| Caucasian-vs-AfricanAmerican |
4.090400E-02 |
| Caucasian-vs-Asian |
1.919380E-01 |
| AfricanAmerican-vs-Asian |
6.311800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.40849579064206E-11 |
| Normal-vs-Female |
5.971500E-02 |
| Male-vs-Female |
3.000900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.839499999574E-07 |
| Normal-vs-Extreme_Weight |
1.10230047312143E-10 |
| Normal-vs-Obese |
1.625480E-04 |
| Normal-vs-Extreme_Obese |
4.780200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.494400E-01 |
| Normal_Weight-vs-Obese |
1.590020E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.824200E-01 |
| Extreme_Weight-vs-Obese |
8.923600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.809600E-01 |
| Obese-vs-Extreme_Obese |
4.589600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.726200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.14890000028012E-08 |
| Normal-vs-Age(61-80Yrs) |
3.13069999924309E-08 |
| Normal-vs-Age(81-100Yrs) |
3.63770000000319E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.059240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.035640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.318230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.689600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.713000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.560400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.19429999223541E-09 |
| Normal-VS-Type2 PRCC |
2.17529999999577E-05 |
| Normal-VS-KIRP CIMP |
6.664400E-01 |
| Normal-VS-Unclassified PRCC |
3.995900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.385600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.364200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.285400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.670380E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.258000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.079700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55999999999335E-05 |
| Normal-vs-N1 |
2.556900E-03 |
| Normal-vs-N2 |
2.45289999999398E-05 |
| N0-vs-N1 |
5.986200E-01 |
| N0-vs-N2 |
4.964200E-02 |
| N1-vs-N2 |
2.205000E-01 |
|
|
